Natco Pharma gets EIR from USFDA for Telangana facility

​​The United States Food and Drug Administration (USFDA) had conducted
pre-approval inspection at the company's drug formulations facility in
Kothur village during the period from March 2 to 6, 2020, Natco Pharma
said in a filing to the BSE.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-eir-from-usfda-for-telangana-facility/articleshow/75372932.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online